264 related articles for article (PubMed ID: 36172750)
1. A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol.
Sharma A; Johnson KB; Bie B; Rhoades EE; Sen A; Kida Y; Hockings J; Gatta A; Davenport J; Arcangelini C; Ritzu J; DeVecchio J; Hughen R; Wei M; Thomas Budd G; Lynn Henry N; Eng C; Foss J; Rotroff DM
Technol Cancer Res Treat; 2022; 21():15330338221127169. PubMed ID: 36172750
[No Abstract] [Full Text] [Related]
2. Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment.
Tamburin S; Park SB; Alberti P; Demichelis C; Schenone A; Argyriou AA
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S40-S51. PubMed ID: 31647157
[TBL] [Abstract][Full Text] [Related]
3. Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment.
Andersen Hammond E; Pitz M; Shay B
Neurorehabil Neural Repair; 2019 Oct; 33(10):792-799. PubMed ID: 31342880
[TBL] [Abstract][Full Text] [Related]
4. Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional study.
Engvall K; Gréen H; Fredrikson M; Lagerlund M; Lewin F; Åvall-Lundqvist E
Breast Cancer Res Treat; 2022 Oct; 195(3):379-391. PubMed ID: 35941422
[TBL] [Abstract][Full Text] [Related]
5. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
[TBL] [Abstract][Full Text] [Related]
6. Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.
Schneider BP; Li L; Radovich M; Shen F; Miller KD; Flockhart DA; Jiang G; Vance G; Gardner L; Vatta M; Bai S; Lai D; Koller D; Zhao F; O'Neill A; Smith ML; Railey E; White C; Partridge A; Sparano J; Davidson NE; Foroud T; Sledge GW
Clin Cancer Res; 2015 Nov; 21(22):5082-5091. PubMed ID: 26138065
[TBL] [Abstract][Full Text] [Related]
7. Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS).
Williams LA; Garcia-Gonzalez A; Mendoza TR; Haq S; Cleeland CS
Support Care Cancer; 2019 Mar; 27(3):1021-1028. PubMed ID: 30094731
[TBL] [Abstract][Full Text] [Related]
8. Persistent taxane-induced neuropathy in elderly patients treated for localized breast cancer.
Pabst L; Velten M; Fischbach C; Kalish M; Pflumio C; Pivot X; Petit T
Breast J; 2020 Dec; 26(12):2376-2382. PubMed ID: 33307596
[TBL] [Abstract][Full Text] [Related]
9. Taxane-induced peripheral neuropathy and quality of life in breast cancer patients.
Salehifar E; Janbabaei G; Alipour A; Tabrizi N; Avan R
J Oncol Pharm Pract; 2020 Sep; 26(6):1421-1428. PubMed ID: 31937190
[TBL] [Abstract][Full Text] [Related]
10. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
[TBL] [Abstract][Full Text] [Related]
11. Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study.
Zhai J; Sun X; Zhao F; Pan B; Li H; Lv Z; Cao M; Zhao J; Mo H; Ma F; Xu B
Breast; 2023 Feb; 67():36-45. PubMed ID: 36586272
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy.
Kleckner IR; Jusko TA; Culakova E; Chung K; Kleckner AS; Asare M; Inglis JE; Loh KP; Peppone LJ; Miller J; Melnik M; Kasbari S; Ossip D; Mustian KM
Breast Cancer Res Treat; 2021 Sep; 189(2):521-532. PubMed ID: 34191201
[TBL] [Abstract][Full Text] [Related]
13. Incidence, description, predictors, and consequences of persistent taxane-induced peripheral neuropathy.
Hertz DL
Curr Opin Support Palliat Care; 2024 Mar; 18(1):30-38. PubMed ID: 38126251
[TBL] [Abstract][Full Text] [Related]
14. Effect of a Complementary/Integrative Medicine Treatment Program on Taxane-Induced Peripheral Neuropathy: A Brief Report.
Ben-Arye E; River Y; Keshet Y; Lavie O; Israeli P; Samuels N
Int J Gynecol Cancer; 2018 Jun; 28(5):1045-1049. PubMed ID: 29561303
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.
Sucheston-Campbell LE; Clay-Gilmour AI; Barlow WE; Budd GT; Stram DO; Haiman CA; Sheng X; Yan L; Zirpoli G; Yao S; Jiang C; Owzar K; Hershman D; Albain KS; Hayes DF; Moore HC; Hobday TJ; Stewart JA; Rizvi A; Isaacs C; Salim M; Gralow JR; Hortobagyi GN; Livingston RB; Kroetz DL; Ambrosone CB
Pharmacogenet Genomics; 2018 Feb; 28(2):49-55. PubMed ID: 29278617
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for taxane-induced peripheral neuropathy in patients with breast cancer.
Liang C; Zhang Y; Chen QY; Chen WF; Chen MZ
Asia Pac J Clin Oncol; 2024 Apr; 20(2):220-227. PubMed ID: 36658674
[TBL] [Abstract][Full Text] [Related]
17. Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans.
Schneider BP; Lai D; Shen F; Jiang G; Radovich M; Li L; Gardner L; Miller KD; O'Neill A; Sparano JA; Xue G; Foroud T; Sledge GW
Oncotarget; 2016 Dec; 7(50):82244-82253. PubMed ID: 27732968
[TBL] [Abstract][Full Text] [Related]
18. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
[TBL] [Abstract][Full Text] [Related]
19. Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN).
Choi V; Park SB; Lacey J; Kumar S; Heller G; Grimison P
BMJ Open; 2024 Jan; 14(1):e076391. PubMed ID: 38195173
[TBL] [Abstract][Full Text] [Related]
20. [Identification of biomarkers and new therapies for taxane-induced peripheral neuropathy].
Koyanagi M; Imai S; Nakagawa T; Matsubara K
Nihon Yakurigaku Zasshi; 2019; 154(5):241-244. PubMed ID: 31735751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
